Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (s)-cloperastine
2. 132301-89-4
3. 1-[2-[(s)-(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine
4. 99v54164fc
5. Unii-99v54164fc
6. L-cloperastine
7. Ncgc00016711-01
8. Cas-14984-68-0
9. Chembl1516068
10. Zinc57251
11. Levocloperastine [who-dd]
12. Q27272245
13. Piperidine, 1-(2-((s)-(4-chlorophenyl)phenylmethoxy)ethyl)-
| Molecular Weight | 329.9 g/mol |
|---|---|
| Molecular Formula | C20H24ClNO |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 329.1546421 g/mol |
| Monoisotopic Mass | 329.1546421 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 318 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Levocloperastine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levocloperastine, including repackagers and relabelers. The FDA regulates Levocloperastine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levocloperastine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levocloperastine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levocloperastine supplier is an individual or a company that provides Levocloperastine active pharmaceutical ingredient (API) or Levocloperastine finished formulations upon request. The Levocloperastine suppliers may include Levocloperastine API manufacturers, exporters, distributors and traders.
click here to find a list of Levocloperastine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Levocloperastine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levocloperastine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levocloperastine GMP manufacturer or Levocloperastine GMP API supplier for your needs.
A Levocloperastine CoA (Certificate of Analysis) is a formal document that attests to Levocloperastine's compliance with Levocloperastine specifications and serves as a tool for batch-level quality control.
Levocloperastine CoA mostly includes findings from lab analyses of a specific batch. For each Levocloperastine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levocloperastine may be tested according to a variety of international standards, such as European Pharmacopoeia (Levocloperastine EP), Levocloperastine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levocloperastine USP).
LOOKING FOR A SUPPLIER?
